Thank you for your time! As you read this material, please keep in mind that we are only one of two Companies in the United States, that we know of, that are making the effort to go " Direct to Consumer" and are less than 2-6 months behind our competitor. I urge you to thoroughly read these material…
Thank you for your time!
As you read this material, please keep in mind that we are only one of two Companies in the United States, that we know of, that are making the effort to go " Direct to Consumer" and are less than 2-6 months behind our competitor. I urge you to thoroughly read these materials and allow for a more in-depth discussion of our prospects, scalability and compliance platform. Thank you again.
>>>> Essentially we are commercializing disruptive technology for management of multi-dose medications. This is a direct to consumer play, and we are a first mover. Our Mantra is RIGHT MEDS, RIGHT TIME, EVERY TIME.
>>>> Below you will find a brief description of the problem and market, and an attachment which presents our company and the solution.
>>>> The Company’s product is a medication management and compliance platform. It was developed to mitigate the largest source of addressable excess costs in the area of health care. Today, health care comprises approximately 15% (or $2.1 trillion) of the US’s $14 trillion dollar economy. Prescription medication represents about $300 billion of that total. According to recent studies, medication mismanagement and non-compliance costs the health care industry about $317 billion, approximately the same size as the market for all prescription medication sales. Additionally, data suggests that as many as 125,000 deaths result annually from this same problem, making it the number one preventable cause of death in the US.
>>>> The company intends to focus on a market comprised of people (40mm) who require 5 or more prescription medications be taken daily. Based on market statistics provided by the US Census Bureau, 37% of seniors fit this criterion. This amounts to approximately14.9 million people over the age of 65. The average senior in this group is spending in excess of $65 per prescription monthly, producing total annual expenditure of some $58 billion annually. In addition to the growth rate of the prescription business at some 6% annually, the demographic group of seniors is adding 10,000 American’s per day. >>>> >>>> v MTM Healthcare Solution Key Differentiators: >>>> >>>> · Unique contracts / relationship with a $100B+ (Fortune 25) pharmaceutical services company. >>>> >>>> o Services (staffing, operations) Contract >>>> >>>> o Purchasing Contract - Prime Vendor Agreement at preferred terms (Drugs, Supplements & OTC products) >>>> >>>> o Technology Sourcing Contract >>>> >>>> · DEA License – Schedules 2–5 (Difficult to obtain in the state of Florida) >>>> · First National Direct-to-Consumer Multi-Dose Medication Management Platform >>>> >>>> · Proprietary Technology Platform – Operations and Production Management >>>> >>>> · Seasoned Management Team and Board of Advisors >>>> >>>> We need $3mm to take us through proof of concept, which is the acquisition of about 4,000 customers, but on a platform capable of functioning on a national scale. We can grow a lot faster with more capital. Our model calls for us to be at around 250,000 customers in three years, which makes this an $800 million plus revenue company (on about $15 mm of capital deployed). We believe social networks can be a powerful force as we build our brand, and have built over almost two years a significant influencers' /follower base.
Team (1)
Sectors MTM Healthcare Solutions serves:
Distribution
Join Axial's Private M&A Platform
MTM Healthcare Solutions connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
